Bayer adds MullenLowe to global advertising agency mix in consumer health

Advertising agency word cloud image
Bayer adds another advertising agency to its roster, notching MullenLowe to care for a portfolio of consumer brands. (Alpha Stock Images)

Bayer’s consumer health division has boosted its advertising agency roster with the addition of Interpublic Group ad agency MullenLowe. The agency won the new business after a competitive agency review by Bayer as it aims to consolidate and modernize its global marketing.

A spokesperson for Bayer Consumer Health said MullenLowe will work on brands based out of its Basel strategic business units and include vitamin supplement Berocca, anti-fungal cream Canesten and heartburn remedy Rennie. That portfolio of brands was previously handled by JWT.

The assignment begins in January 2020 and will be handled out of MullenLowe offices in the U.K.

Sponsored by Lubrizol Life Science

[Webinar] Cannabinoid Formulation - from Farm to Pharma

Wednesday, June 24, 2020 | 12pm ET / 9am PT

A handful of cannabinoid-based pharmaceutical products are on the market today, and an ever-growing number are in the global development pipeline. This webinar will explore key considerations in developing cannabinoid-based pharmaceutical products, including an overview of global pharmaceutical cannabinoid usage today, common challenges formulating with CBD and other cannabinoids, and more.

Other agencies—including Omnicom Group’s BBDO, which handles brands including Aspirin and Claritin—will also continue to work on Bayer consumer brands.

RELATED: Bayer offloads Dr. Scholl's foot care brand for $585M as major revamp presses on

Bayer bought Merck & Co.’s consumer business in 2014, but since then, the division has been the subject of many selloff rumors. After much buzz about an entire division sale, Bayer instead last year sold off two big brands it got from Merck—Coppertone sun care and Dr. Scholl’s foot care products—in two separate deals for a combined $1.14 billion.

Bayer’s consumer health unit delivered sales of €1.29 billion ($1.23 billion) in Q3, which was a 3.7% increase year over year, the company reported.

Suggested Articles

The antidepressant Zoloft and its generics are in short supply as the COVID-19 pandemic has caused higher demand and manufacturing interruptions.

WuXi AppTec has appointed Celgene CAR-T program veteran David Chang to lead its cell and gene therapy CDMO, WuXi Advanced Therapies.

Merck CEO Ken Frazier has spoken passionately about racism before. Monday, amid protests over George Floyd's death, he made that passion personal.